Is Hunan Pharmaceutical Group Co., Ltd. a state-owned enterprise?

Hunan Pharmaceutical Group Co., Ltd. is a state-owned enterprise. Hunan Pharmaceutical Group Co., Ltd. was approved by Hunan Provincial Party Committee, Provincial Government and Provincial State-owned Assets Supervision and Administration Commission, initiated by Hunan Light Industry Salt Industry Group, and established on 20191in conjunction with the leading investment of emerging industries in Hunan Province and people's pharmacies and other related advantageous enterprises in the medical field in the province. In September 2022, with the layout optimization and structural adjustment of provincial state-owned enterprises, Hunan Pharmaceutical Development Investment Group Co., Ltd. took over Hunan Light Industry Salt Industry Group, holding 40% of the shares of Hunan Pharmaceutical Group Co., Ltd. and became the new shareholder of Hunan Pharmaceutical Group.

The company's main business

The company is located in Jinxia Economic Development Zone, Kaifu District, Changsha City, with a registered capital of 654.38 billion yuan. Its business scope covers R&D, production, sales and service of drugs and medical device consumables, investment and operation of pharmaceutical industry, pharmaceutical supply chain finance, Internet medicine and medical treatment. It is a state-owned mixed-ownership enterprise, a AAA-level enterprise with national credit rating, a-level enterprise with provincial SASAC, a provincial medicine reserve enterprise and a provincial public emergency material reserve enterprise.

Business philosophy of the company

The company adheres to the basic concepts of government guidance, enterprise subject, market operation and open cooperation, highlights the core values of customer-oriented, struggle-oriented, innovation-oriented, quality-oriented and performance-oriented, focuses on the positioning of provincial-level pharmaceutical head enterprises and circulation "main channels", adheres to the business purpose of "focusing on profit, paying equal attention to development and risk control" and revolves around the differentiation of "technology+platform+equipment"

Business scope of the company

Licensed items: pharmaceutical production; Drug wholesale; The second kind of medical device production; Production of the third kind of medical devices; Food sales; Liquor business; Veterinary drug management; Road freight transport (excluding dangerous goods); Drug import and export; Commissioned the production of drugs; Chinese herbal medicine decocting service; The second kind of value-added telecommunications services; Internet information service; Drug Internet information service; Internet information service for medical devices; Class I ray device sales; Sales of Class I radioactive sources; Sales of Class II, III, IV and V radioactive sources; II, III ray device sales; Sales of disinfection equipment; Inspection and testing services; The third kind of medical equipment rental; The third kind of medical device management. (Projects subject to approval according to law can only be operated after approval by relevant departments. Specific business projects shall be subject to the approval documents or licenses of relevant departments. )

General projects: first-class medical device production; Sales of first-class medical devices; Sales of second-class medical devices; Sales of formula food for special medical use; Sales of sanitary products and disposable medical products; Internet sales (except for the sale of goods that need permission); Internet sales of food (prepackaged foods only); Agricultural and sideline products sales.